SCHEMBL24310560

SCHEMBL24310560

COc1cccc(-c2cc(Oc3ccc(N4CCN(C)CC4)cc3)nc(NSc3cnn(C)c3)n2)c1CCCC(C)C

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ IRAK4 Q9NWZ3 1/20 0.34
▸ BRD4 O60885 5/20 0.33
▸ QPCT Q16769 1/20 0.33
▸ MAP4K1 Q92918 2/20 0.33
▸ EGFR P00533 3/20 0.32
▸ PTK2 Q05397 3/20 0.32
▸ JAK2 O60674 2/20 0.32
▸ JAK3 P52333 1/20 0.32
▸ DCLK1 O15075 1/20 0.32
▸ LRRK2 Q5S007 1/20 0.32
▸ CDK4 P11802 2/20 0.32
▸ CCND1 P24385 1/20 0.32
▸ CCND2 P30279 1/20 0.32
▸ CCND3 P30281 1/20 0.32
▸ INSR P06213 1/20 0.32
▸ CYP3A4 P08684 1/20 0.32
▸ ALK Q9UM73 1/20 0.32
▸ AURKA O14965 1/20 0.31
▸ NPC1 O15118 1/20 0.31
▸ TP53 P04637 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24310517 0.88 CDK4 (0.33) BRD4MAP4K1CDK4CCND1CCND2
SCHEMBL26807256 0.86 BRD4 (0.36) IRAK4BRD4QPCTEGFRPTK2
SCHEMBL29566837 0.86 BRD4 (0.36) IRAK4BRD4QPCTEGFRPTK2
SCHEMBL24310306 0.86 CDK4 (0.34) BRD4MAP4K1EGFRDCLK1LRRK2
SCHEMBL24310561 0.82 QPCT (0.32) BRD4QPCTMAP4K1EGFRPTK2
SCHEMBL24309623 0.81 MAP4K1 (0.37) BRD4MAP4K1EGFR
SCHEMBL24309807 0.80 CDK4 (0.33) BRD4MAP4K1CDK4ALKNPC1
SCHEMBL24310522 0.79 MAP4K1 (0.31) BRD4MAP4K1CDK4CCND1CCND2
SCHEMBL24310329 0.78 MET (0.32) MAP4K1CDK4
SCHEMBL24310319 0.78 BRD4 (0.32) BRD4MAP4K1EGFRCDK4CCND1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022076627-A1 MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR VERTEX PHARMACEUTICALS INCORPORATED (US) 2022-04-14 — — WO disclosed
Send feedback